在长期使用双酸盐治疗后,非典型的股骨骨折和不典型的股骨骨折的白人绝经后妇女之间,骨基组学上的差异
Shijing Qiu1, Ruban Dhaliwal2,3, George Divine4
1Bone and Mineral Research Laboratory, Henry Ford Health, Detroit, MI 48202, USA.
概括
接受双酸盐 (BPs) 治疗的骨质疏松症患者经历非典型的股骨骨折 (AFFs) 时,骨厚度降低,骨再吸收标记较高. 较长的BP治疗持续时间增加了AFF风险.
科学领域:
- 骨生物学 骨生物学 骨生物学
- 骨质疏松症研究 骨质疏松症研究
- 生物材料科学 生物材料科学
背景情况:
- 抗吸收药物,包括双酸盐 (BPs),对于治疗骨质疏松症至关重要.
- 非典型的股骨骨折 (AFF) 是长期接受高血压治疗的患者的潜在并发症.
- 骨组织形状测量可以提供关于AFF发展背后的机制的见解.
研究的目的:
- 为了研究与没有AFFs的患者之间的过时性结核活检中的骨组织结构测量差异.
- 为了评估骨微观结构,骨周转率和骨质疏松症患者治疗阿伦德罗酸盐的AFF发生之间的关联.
- 为了确定长时间的双酸盐治疗持续时间是否会影响AFF风险.
主要方法:
- 对52名绝经后妇女进行过关骨活检,有 (n=20) 和没有 (n=32) AFF.
- 所有患者都接受了连续的阿伦德罗纳特治疗,持续时间为4至17年.
- 分析了骨组织形态测量终点在无效,皮质内和内皮质包裹中.
主要成果:
- AFF患者的阿伦德罗纳特治疗持续时间明显长 (10.7年而不是8.0年).
- AFF患者在状和皮质内外包中表现出较低的壁厚 (W.Th).
- AFF患者在皮层内表现出较高的骨质细胞表面 (Oc.S/BS) 和侵蚀表面 (ES/BS),骨形成标志物没有显著差异.
结论:
- 接受双酸盐治疗的AFF患者在阴道和皮质包裹中减少了表面骨厚.
- 在AFF和非AFF患者之间,阴茎骨的骨周转率相似.
- 较长的双酸盐治疗持续时间与AFF的可能性增加有关.
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


